Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disci/Rhus toxicodendron comp. vs placebo vs waiting list in chronic low back pain
2006-006390-24Phase 4Completed
- Sponsor
- WALA Heilmittel GmbH
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of discus intervertebralis + rhus toxicodendron in chronic low back pain (CLBP) (3 arms), sponsored by WALA Heilmittel GmbH. Primary endpoint: Average pain intensity over the last 7 days at 8 weeks. Started Jan 2007; status: completed.
02
Drugs
discus intervertebralis + rhus toxicodendron
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on 2006-006390-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006390-24.